Reliever Salbutamol Use Appears Linked To Risk Of COPD Exacerbation

By Dr Deepu

Healio (9/12) reported that research indicated that “short-term and long-term use of short-acting beta 2-agonist salbutamol 90 μg appeared associated with increased short- and long-term exacerbation of chronic obstructive pulmonary disease.” The findings were published in BMC Pulmonary Medicine.